Stockscreener 앱 받기
2.01
0.25%
-0.005
전일 마감가:
$2.015
열려 있는:
$2.1
하루 거래량:
46,716
Relative Volume:
0.69
시가총액:
$4.95M
수익:
$77,900
순이익/손실:
$-8.05M
주가수익비율:
-0.2178
EPS:
-9.2296
순현금흐름:
$-7.47M
1주 성능:
-17.96%
1개월 성능:
-30.21%
6개월 성능:
-39.27%
1년 성능:
-71.83%
1일 변동 폭
$1.95
$2.10
1주일 범위
$1.95
$2.51
52주 변동 폭
$1.95
$12.03
Aclarion Inc Stock (ACON) Company Profile
명칭
Aclarion Inc
전화
833 275 2266
주소
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, HQY, TEM, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.01 | 5.47M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
200.62 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.43 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
100.80 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
43.36 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
48.29 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion, Inc. Revenue Breakdown – BOATS:ACON - TradingView
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ACON|Aclarion Inc|Price:2.420|Chg%:-0.030 - TradingKey
Aclarion Market Sentiment - Benzinga España
TradingKey - TradingKey
Aclarion, Inc. Revenue Breakdown – TRADEGATE:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – NASDAQ:ACONW - TradingView
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice - Ortho Spine News
Aclarion Nociscan Case Reports 95% Relief Without Classic MRI Signs - Stock Titan
Aclarion, Inc. Warrant 2022- on Aclarion Financial Disclosures & SEC Filings - TradingView
Return on equity % of Aclarion, Inc. – TRADEGATE:IT20 - TradingView
Aclarion Inc. (ACON) Slides 2.6% as Support Levels Face Renewed PressureDouble Bottom - dars.gov.et
Aclarion Inc. (ACON) Faces Resistance After 5.41% Decline – Key Levels in FocusRatio Spread Trade - dars.gov.et
Price to sales forward of Aclarion, Inc. – NASDAQ:ACONW - TradingView
Number of shareholders of Aclarion, Inc. – NASDAQ:ACONW - TradingView
Price to earnings forward of Aclarion, Inc. – BOATS:ACONW - TradingView
ACON Q1 2026 Earnings: EPS Surprises to the Upside Despite Stock DeclinePerformance Review - DonanımHaber
Aclarion Inc. (ACON) Consolidates Near $3.02 as Micro-Cap Healthcare Stock Eyes Resistance at $3.17Bullish Sentiment - dars.gov.et
Aclarion Announces Texas Spine Care Center as New CLARITY Site - marketscreener.com
Aclarion adds Texas Spine Care Center to CLARITY trial By Investing.com - Investing.com Nigeria
Aclarion adds Texas Spine Care Center to CLARITY trial - Investing.com
Aclarion expands CLARITY trial with Texas spine center - Stock Titan
Aclarion Inc. Warrant (ACONW) Slips 6.85%, Hovers at Critical $0.02 LevelBreakaway Gap - dars.gov.et
Aclarion Inc. Warrant (ACONW) Slips Again: Warrants Trade Near $0.02 Amid Thin VolumeShort Term Trading Ideas - dars.gov.et
ACONW Extends Decline: A Closer Look at Aclarion Inc. WarrantsAnalyst Upgrade Stocks - dars.gov.et
Aclarion Inc. Q1 2026 Earnings: EPS Surprise Drives Stock Rally Amid Revenue AbsenceEarnings Turnaround - dars.gov.et
ACON Q1 2026 Earnings: EPS Surpasses Analyst Estimates Despite Lack of Revenue DisclosureFull Year Guidance - dars.gov.et
Enterprise value to EBIT forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
Price to book forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
A412BH Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion, Inc. Actuals & Estimates (NASDAQ:ACON) - TradingView
ACON Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion Inc (ACONW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc. (ACON) Q1 2026 Earnings: Narrower-than-expected Loss Drives EPS Beat, Yet Shares Slide 4.9%EPS Growth Report - DonanımHaber
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates with 15% Beat Despite No RevenueGAAP Earnings Report - dars.gov.et
Aclarion Inc (ACONW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ACON Q1 2026 Earnings: EPS Surprises Positively Despite Absence of RevenueAdjusted Earnings Analysis - Bölüm Sonu Canavarı
Aclarion Inc. Warrant (ACONW) Surges 38% From Penny Levels – But Caution WarrantedBPI Bull Correction - Město Břeclav
Aclarion Inc. Holds Steady Near Key Resistance Level (ACON)RTH Profile - dars.gov.et
Aclarion (ACON) upgraded to buy: Here's why - MSN
Aclarion Inc (ACONW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACONW) Institutional Confidence - TradingKey
Aclarion Inc (ACONW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACONW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACONW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACONW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion Inc (ACON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aclarion Inc 주식 (ACON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
1.29%
0.08%
자본화:
|
볼륨(24시간):